Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne T Nies

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Clinical and Translational Science|May 8, 2026
Feed-Forward Deep Neural Networks Predict Substrate-Specific Effects of Transporter Variants to Explain Drug Response VariabilityYoomi Park, Yitian Zhou, Ming Xiao, et al.
Expert Opinion on Pharmacotherapy|July 13, 2012
Retigabine/Ezogabine, a KCNQ/K(V)7 channel opener: pharmacological and clinical dataGökce Orhan, Thomas V Wuttke, Anne T Nies, et al.
Hepatology (Baltimore, Md.)|July 29, 2003
Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membraneMaria Rius, Anne T Nies, Johanna Hummel-Eisenbeiss, et al.
European Journal of Biochemistry|April 16, 2002
Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2)Anne T Nies, Jörg König, Yunhai Cui, et al.
Trends in Pharmacological Sciences|September 24, 2016
Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase InhibitorsClaudia Neul, Elke Schaeffeler, Alex Sparreboom, et al.
Plos One|July 23, 2011
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs)Anne T Nies, Ute Hofmann, Claudia Resch, et al.
Hepatology (Baltimore, Md.)|October 24, 2017
Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemiaRyoichi Fujiwara, Mathias Haag, Elke Schaeffeler, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 18, 2021
Differential <i>in vitro</i> interactions of the Janus kinase inhibitor ruxolitinib with human SLC drug transportersArnaud Bruyère, Marc Le Vée, Elodie Jouan, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 22, 2002
A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2)Verena Keitel, Anne T Nies, Manuela Brom, et al.
Pharmaceutics|April 3, 2021
Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake TransportersAnne T Nies, Jörg König, Ute Hofmann, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Clinical and Translational Science|May 8, 2026
Feed-Forward Deep Neural Networks Predict Substrate-Specific Effects of Transporter Variants to Explain Drug Response VariabilityYoomi Park, Yitian Zhou, Ming Xiao, et al.
Expert Opinion on Pharmacotherapy|July 13, 2012
Retigabine/Ezogabine, a KCNQ/K(V)7 channel opener: pharmacological and clinical dataGökce Orhan, Thomas V Wuttke, Anne T Nies, et al.
Hepatology (Baltimore, Md.)|July 29, 2003
Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membraneMaria Rius, Anne T Nies, Johanna Hummel-Eisenbeiss, et al.
European Journal of Biochemistry|April 16, 2002
Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2)Anne T Nies, Jörg König, Yunhai Cui, et al.
Trends in Pharmacological Sciences|September 24, 2016
Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase InhibitorsClaudia Neul, Elke Schaeffeler, Alex Sparreboom, et al.
Plos One|July 23, 2011
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs)Anne T Nies, Ute Hofmann, Claudia Resch, et al.
Hepatology (Baltimore, Md.)|October 24, 2017
Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemiaRyoichi Fujiwara, Mathias Haag, Elke Schaeffeler, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 18, 2021
Differential <i>in vitro</i> interactions of the Janus kinase inhibitor ruxolitinib with human SLC drug transportersArnaud Bruyère, Marc Le Vée, Elodie Jouan, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 22, 2002
A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2)Verena Keitel, Anne T Nies, Manuela Brom, et al.
Pharmaceutics|April 3, 2021
Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake TransportersAnne T Nies, Jörg König, Ute Hofmann, et al.
Pageof 7